LeonaBio, Inc. is a clinical-stage biopharmaceutical firm focused on creating innovative therapeutics to address significant medical needs, specifically targeting conditions like amyotrophic lateral sclerosis (ALS) and treatment-resistant metastatic breast cancer. Our lead candidates, lasofoxifene and ATH-1105, represent a new approach in treating these challenging diseases where traditional options fall short.
No jobs found. Subscribe below to get notified when we find something for you.
Searching